The “best” of cholesterols, the “worst” of cholesterols: A tale of two receptors
Open Access
- 14 April 1998
- journal article
- editorial
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 95 (8) , 4077-4080
- https://doi.org/10.1073/pnas.95.8.4077
Abstract
Cardiovascular disease is the number one killer in the U.S., and atherosclerosis is the major cause of heart disease and stroke (1). It is widely appreciated that cholesterol plays an important role in atherogenesis. Normally, most cholesterol serves as a structural element in the walls of cells, whereas much of the rest is in transit through the blood or functions as the starting material for the synthesis of bile acids in the liver, steroid hormones in endocrine cells (e.g., adrenal gland, ovary, testes), and vitamin D in skin. The transport of cholesterol and other lipids through the circulatory system is facilitated by their packaging into lipoprotein carriers. These spherical particles comprise protein and phospholipid shells surrounding a core of neutral lipid, including unesterified (“free”) or esterified cholesterol and triglycerides. Risk for atherosclerosis increases with increasing concentrations of low density lipoprotein (LDL) cholesterol whereas risk is inversely proportional to the levels of high density lipoprotein (HDL) cholesterol (2, 3). The receptor-mediated control of plasma LDL levels has been well-defined (4, 5), and very recent studies have now provided new insights into HDL metabolism (6–11). In 1974, Michael Brown, Joseph Goldstein, and colleagues began publishing a classic series of papers that described the receptor-mediated cellular metabolism of LDL (4, 12). Their work defined how the LDL receptor influences LDL metabolism in the body and helps to determine blood LDL levels. Fig. 1 summarizes in a simplified form the role of LDL in cholesterol transport. In brief, the liver synthesizes a precursor lipoprotein (very low density lipoprotein, VLDL) that is converted during circulation to intermediate density lipoprotein (IDL) and then to LDL (13). The majority of the LDL receptors expressed in the body are on the surfaces of liver cells, although virtually all other tissues (“peripheral tissues”) …Keywords
This publication has 50 references indexed in Scilit:
- Ribonucleic Acid Expression of the CLA-1 Gene, a Human Homolog to Mouse High Density Lipoprotein Receptor SR-BI, in Human Adrenal Tumors and Cultured Adrenal CellsJournal of Clinical Endocrinology & Metabolism, 1997
- Cloning, Characterization, and Cellular Distribution of Rat Scavenger Receptor Class B Type I (SRBI) in the OvaryBiochemical and Biophysical Research Communications, 1997
- Scavenger Receptor BI (SR-BI) Is Up-regulated in Adrenal Gland in Apolipoprotein A-I and Hepatic Lipase Knock-out Mice as a Response to Depletion of Cholesterol StoresPublished by Elsevier ,1996
- STRUCTURES AND FUNCTIONS OF MULTILIGAND LIPOPROTEIN RECEPTORS: Macrophage Scavenger Receptors and LDL Receptor-Related Protein (LRP)Annual Review of Biochemistry, 1994
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.Journal of Clinical Investigation, 1993
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989
- Beyond CholesterolNew England Journal of Medicine, 1989
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989
- Receptor-Mediated Endocytosis: Concepts Emerging from the LDL Receptor SystemAnnual Review of Cell Biology, 1985
- Uptake of rat plasma HDL subfractions labeled with [3H]cholesteryl linoleyl ether or with 125I by cultured rat hepatocytes and adrenal cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984